Ultragenyx Pharmaceutical Cash from Investing (TTM) Insights

Ultragenyx Pharmaceutical Inc (RARE)

40.88 -0.30 (-0.74%) USD | NASDAQ | May 10, 16:00

40.88 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	151.13M
December 31, 2023	168.00M
September 30, 2023	103.42M
June 30, 2023	-122.74M
March 31, 2023	-142.99M
December 31, 2022	-291.65M
September 30, 2022	-51.00M
June 30, 2022	70.10M
March 31, 2022	-50.31M
December 31, 2021	-195.37M
September 30, 2021	-166.53M
June 30, 2021	-221.53M
March 31, 2021	-266.42M
December 31, 2020	-179.12M
September 30, 2020	-209.76M
June 30, 2020	-34.68M
March 31, 2020	-6.971M
December 31, 2019	-13.04M
September 30, 2019	-6.744M
June 30, 2019	-69.85M
March 31, 2019	-63.50M

Date	Value
December 31, 2018	-33.33M
September 30, 2018	-49.50M
June 30, 2018	-35.92M
March 31, 2018	-4.926M
December 31, 2017	55.48M
September 30, 2017	-9.062M
June 30, 2017	13.66M
March 31, 2017	58.72M
December 31, 2016	91.12M
September 30, 2016	64.71M
June 30, 2016	-131.51M
March 31, 2016	-266.51M
December 31, 2015	-292.35M
September 30, 2015	-275.81M
June 30, 2015	-145.64M
March 31, 2015	-62.11M
December 31, 2014	-123.44M
September 30, 2014	-95.31M
June 30, 2014	-82.55M
March 31, 2014	-98.03M
December 31, 2013	-47.73M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-291.65M

Minimum

Dec 2022

168.00M

Maximum

Dec 2023

-76.80M

Average

-60.42M

Median

Cash from Investing (TTM) Benchmarks